(19)
(11) EP 1 513 951 A2

(12)

(88) Date of publication A3:
29.12.2004

(43) Date of publication:
16.03.2005 Bulletin 2005/11

(21) Application number: 03726880.2

(22) Date of filing: 15.05.2003
(51) International Patent Classification (IPC)7C12Q 1/68
(86) International application number:
PCT/US2003/015313
(87) International publication number:
WO 2003/097802 (27.11.2003 Gazette 2003/48)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 16.05.2002 US 380912 P

(71) Applicant: Avalon Pharmaceuticals
Germantown,Maryland 20876 (US)

(72) Inventors:
  • WEAVER, Zoe
    New Market, MD 21774 (US)
  • EBNER, Reinhard
    Gaithersburg, MD 20878 (US)

(74) Representative: Ruffles, Graham Keith 
Marks & Clerk66-68 Hills Road
Cambridge,Cambridgeshire, CB2 1LA
Cambridge,Cambridgeshire, CB2 1LA (GB)

   


(54) CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY